Accrued Expenses and Other Liabilities

9 Months Ended

Sep. 30, 2022

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

	September 30,		December 31,
	2022		2021
Income tax payable	$	1,092,558	$	—
Accrued preclinical and clinical trial expenses		721,923		955,013
Other expenses		725,723		631,312
Compensation and related benefits		313,526		459,178
Accrued manufacturing expenses		959,443		179,173
Accrued franchise tax		10,000		195,000
	$	3,823,173	$	2,419,676